BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gremese E, Ferraccioli G. The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev. 2011;10:582-589. [PMID: 21539940 DOI: 10.1016/j.autrev.2011.04.018] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Tolusso B, Gigante MR, Alivernini S, Petricca L, Fedele AL, Di Mario C, Aquilanti B, Magurano MR, Ferraccioli G, Gremese E. Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis. Front Med (Lausanne) 2018;5:207. [PMID: 30123797 DOI: 10.3389/fmed.2018.00207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
2 Gunduz M, Gunduz E, Kircelli F, Okur N, Ozkaya M. Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism. Int J Endocrinol 2012;2012:109797. [PMID: 22505888 DOI: 10.1155/2012/109797] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
3 Caso F, Postiglione L, Covelli B, Ricciardone M, Di Spigna G, Formisano P, D’esposito V, Girolimetto N, Tasso M, Peluso R, Navarini L, Ciccozzi M, Margiotta DPE, Oliviero F, Afeltra A, Punzi L, Del Puente A, Scarpa R, Costa L. Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis”. Clin Rheumatol 2019;38:2547-52. [DOI: 10.1007/s10067-019-04619-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
4 Costa L, Caso F, Ramonda R, Del Puente A, Cantarini L, Darda MA, Caso P, Lorenzin M, Fiocco U, Punzi L, Scarpa R. Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study. Immunol Res 2015;61:147-53. [PMID: 25395342 DOI: 10.1007/s12026-014-8595-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
5 Parra-Salcedo F, Contreras-Yáñez I, Elías-López D, Aguilar-Salinas CA, Pascual-Ramos V. Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity. Arthritis Res Ther 2015;17:34. [PMID: 25889060 DOI: 10.1186/s13075-015-0549-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
6 Mavrogeni S, Sfikakis P, Dimitroulas T, Kolovou G, Kitas GD. Edema and fibrosis imaging by cardiovascular magnetic resonance: how can the experience of Cardiology be best utilized in rheumatological practice? Semin Arthritis Rheum 2014;44:76-85. [PMID: 24582213 DOI: 10.1016/j.semarthrit.2014.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
7 Sarmiento-Monroy JC, Amaya-Amaya J, Espinosa-Serna JS, Herrera-Díaz C, Anaya JM, Rojas-Villarraga A. Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america. Arthritis 2012;2012:371909. [PMID: 23193471 DOI: 10.1155/2012/371909] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
8 Carbone F, Bonaventura A, Liberale L, Paolino S, Torre F, Dallegri F, Montecucco F, Cutolo M. Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents. Clin Rev Allergy Immunol 2020;58:1-14. [PMID: 30259381 DOI: 10.1007/s12016-018-8714-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
9 Rostom S, Mengat M, Lahlou R, Hari A, Bahiri R, Hajjaj-Hassouni N. Metabolic syndrome in rheumatoid arthritis: case control study. BMC Musculoskelet Disord 2013;14:147. [PMID: 23621997 DOI: 10.1186/1471-2474-14-147] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
10 Olofsson P, Hultqvist M, Hellgren LI, Holmdahl R. Phytol: A Chlorophyll Component with Anti-inflammatory and Metabolic Properties. In: Jacob C, Kirsch G, Slusarenko A, Winyard PG, Burkholz T, editors. Recent Advances in Redox Active Plant and Microbial Products. Dordrecht: Springer Netherlands; 2014. pp. 345-59. [DOI: 10.1007/978-94-017-8953-0_13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
11 Behl T, Kaur I, Sehgal A, Zengin G, Brisc C, Brisc MC, Munteanu MA, Nistor-Cseppento DC, Bungau S. The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients. Int J Mol Sci 2020;21:E9505. [PMID: 33327502 DOI: 10.3390/ijms21249505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Jurgens MS, Jacobs JWG, Geenen R, Bossema ER, Bakker MF, Bijlsma JWJ, van Albada-kuipers IA, Ehrlich JC, Lafeber FPJG, Welsing PMJ; on behalf of The Utrecht Arthritis Cohort Study Group. Increase of body mass index in a tight controlled methotrexate-based strategy with prednisone in early rheumatoid arthritis: Side effect of the prednisone or better control of disease activity? Arthritis Care Res 2013;65:88-93. [DOI: 10.1002/acr.21797] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
13 Dean E, Gormsen Hansen R. Prescribing optimal nutrition and physical activity as "first-line" interventions for best practice management of chronic low-grade inflammation associated with osteoarthritis: evidence synthesis. Arthritis 2012;2012:560634. [PMID: 23346399 DOI: 10.1155/2012/560634] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
14 Tolusso B, Alivernini S, Gigante MR, Ferraccioli G, Gremese E. Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations. Expert Rev Clin Immunol 2016;12:751-62. [PMID: 26950427 DOI: 10.1586/1744666X.2016.1159132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
15 Gibbs JE, Ray DW. The role of the circadian clock in rheumatoid arthritis. Arthritis Res Ther 2013;15:205. [PMID: 23427807 DOI: 10.1186/ar4146] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
16 Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina AR, Favalli EG, Erre G, Gorla R, Galeazzi M. Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine. Arthritis Care Res (Hoboken). 2013;65:94-100. [PMID: 22730143 DOI: 10.1002/acr.21768] [Cited by in Crossref: 116] [Cited by in F6Publishing: 96] [Article Influence: 14.5] [Reference Citation Analysis]
17 Hollan I, Dessein PH, Ronda N, Wasko MC, Svenungsson E, Agewall S, Cohen-Tervaert JW, Maki-Petaja K, Grundtvig M, Karpouzas GA, Meroni PL. Prevention of cardiovascular disease in rheumatoid arthritis. Autoimmun Rev 2015;14:952-69. [PMID: 26117596 DOI: 10.1016/j.autrev.2015.06.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 8.5] [Reference Citation Analysis]
18 Prieto-Potín I, Roman-Blas JA, Martínez-Calatrava MJ, Gómez R, Largo R, Herrero-Beaumont G. Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration. Arthritis Res Ther 2013;15:R81. [PMID: 23941259 DOI: 10.1186/ar4261] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
19 Watad A, Agmon-levin N, Gilburd B, Lidar M, Amital H, Shoenfeld Y. Predictive value of anti-citrullinated peptide antibodies: a real life experience. Immunol Res 2014;60:348-55. [DOI: 10.1007/s12026-014-8566-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
20 Gabriel SE, Crowson CS. Risk factors for cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 2012;24:171-6. [PMID: 22249350 DOI: 10.1097/BOR.0b013e32834ff2fd] [Cited by in Crossref: 50] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
21 Pandey PK, Swami A, Biswas TK, Thakuria R. Prevalence of Metabolic Syndrome in Treatment Naïve Rheumatoid Arthritis and Correlation With Disease Parameters. Arch Rheumatol 2017;32:46-52. [PMID: 30375525 DOI: 10.5606/ArchRheumatol.2017.5949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 States JC, Singh AV, Knudsen TB, Rouchka EC, Ngalame NO, Arteel GE, Piao Y, Ko MS. Prenatal arsenic exposure alters gene expression in the adult liver to a proinflammatory state contributing to accelerated atherosclerosis. PLoS One 2012;7:e38713. [PMID: 22719926 DOI: 10.1371/journal.pone.0038713] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
23 Amaya-Amaya J, Montoya-Sánchez L, Rojas-Villarraga A. Cardiovascular involvement in autoimmune diseases. Biomed Res Int 2014;2014:367359. [PMID: 25177690 DOI: 10.1155/2014/367359] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
24 Bremer AA, Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. J Obes. 2013;2013:393192. [PMID: 23653857 DOI: 10.1155/2013/393192] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 10.0] [Reference Citation Analysis]
25 Damen MS, Popa CD, Netea MG, Dinarello CA, Joosten LA. Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases. Atherosclerosis 2017;264:83-91. [DOI: 10.1016/j.atherosclerosis.2017.07.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
26 Yu Y, Wang Z, Ding Q, Yu X, Yang Q, Wang R, Fang Y, Qi W, Liao J, Hu W, Zhu Y. The Preparation of a Novel Poly(Lactic Acid)-Based Sustained H2S Releasing Microsphere for Rheumatoid Arthritis Alleviation. Pharmaceutics 2021;13:742. [PMID: 34069878 DOI: 10.3390/pharmaceutics13050742] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 López-mejías R, Castañeda S, González-juanatey C, Corrales A, Ferraz-amaro I, Genre F, Remuzgo-martínez S, Rodriguez-rodriguez L, Blanco R, Llorca J, Martín J, González-gay MA. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. Autoimmunity Reviews 2016;15:1013-30. [DOI: 10.1016/j.autrev.2016.07.026] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 14.2] [Reference Citation Analysis]
28 Chimenti MS, Triggianese P, Conigliaro P, Candi E, Melino G, Perricone R. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis 2015;6:e1887. [PMID: 26379192 DOI: 10.1038/cddis.2015.246] [Cited by in Crossref: 89] [Cited by in F6Publishing: 74] [Article Influence: 14.8] [Reference Citation Analysis]
29 Amaya-amaya J, Sarmiento-monroy JC, Mantilla R, Pineda-tamayo R, Rojas-villarraga A, Anaya J. Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunol Res 2013;56:267-86. [DOI: 10.1007/s12026-013-8398-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
30 Day AL, Singh JA. Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction? Drugs Aging 2019;36:493-510. [PMID: 30953327 DOI: 10.1007/s40266-019-00653-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
31 Krentz AJ, Viljoen A, Sinclair A. Insulin resistance: a risk marker for disease and disability in the older person. Diabet Med 2013;30:535-48. [DOI: 10.1111/dme.12063] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
32 George MD, Baker JF. The Obesity Epidemic and Consequences for Rheumatoid Arthritis Care. Curr Rheumatol Rep 2016;18:6. [PMID: 26739963 DOI: 10.1007/s11926-015-0550-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
33 Weix J, Förger F, Häupl T, Surbek D, Østensen M, Villiger PM. Influence of pregnancy on the adipocytokine and peroxisome proliferator-activated receptor pathways in peripheral blood mononuclear cells from healthy donors and rheumatoid arthritis patients. Arthritis Rheum 2012;64:2095-103. [PMID: 22231457 DOI: 10.1002/art.34375] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
34 Selmi C. Autoimmunity in 2011. Clin Rev Allergy Immunol. 2012;43:194-206. [PMID: 22733376 DOI: 10.1007/s12016-012-8330-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
35 Ursini F, Russo E, Ruscitti P, Giacomelli R, De Sarro G. The effect of non-TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis. Autoimmun Rev 2018;17:399-404. [PMID: 29452240 DOI: 10.1016/j.autrev.2017.11.030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
36 Desai SS, Myles JD, Kaplan MJ. Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis. Arthritis Res Ther 2012;14:R270. [PMID: 23237607 DOI: 10.1186/ar4118] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
37 da Silva TF, Levy-Neto M, Bonfá E, Pereira RM. High prevalence of metabolic syndrome in Takayasu arteritis: increased cardiovascular risk and lower adiponectin serum levels. J Rheumatol 2013;40:1897-904. [PMID: 24037555 DOI: 10.3899/jrheum.130162] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
38 Jager NA, Teteloshvili N, Zeebregts CJ, Westra J, Bijl M. Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: A forthcoming marker for cardiovascular risk? Autoimmunity Reviews 2012;11:621-6. [DOI: 10.1016/j.autrev.2011.11.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
39 Andrés Cerezo L, Kuklová M, Hulejová H, Vernerová Z, Pešáková V, Pecha O, Veigl D, Haluzík M, Pavelka K, Vencovský J, Šenolt L. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels. Cytokine 2013;64:441-7. [DOI: 10.1016/j.cyto.2013.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
40 Costa L, Caso F, Atteno M, Del Puente A, Darda MA, Caso P, Ortolan A, Fiocco U, Ramonda R, Punzi L, Scarpa R. Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients. Clin Rheumatol 2014;33:833-9. [PMID: 23959447 DOI: 10.1007/s10067-013-2369-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
41 Lee SG, Kim JM, Lee SH, Kim KH, Kim JH, Yi JW, Jung WJ, Park YE, Park SH, Lee JW, Baek SH, Lee JH, Kim GT. Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects? Korean J Intern Med 2013;28:206-15. [PMID: 23526131 DOI: 10.3904/kjim.2013.28.2.206] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
42 Hollan I, Meroni PL, Ahearn JM, Cohen Tervaert JW, Curran S, Goodyear CS, Hestad KA, Kahaleh B, Riggio M, Shields K, Wasko MC. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 2013;12:1004-15. [PMID: 23541482 DOI: 10.1016/j.autrev.2013.03.013] [Cited by in Crossref: 162] [Cited by in F6Publishing: 128] [Article Influence: 20.3] [Reference Citation Analysis]
43 Wang CP, Lorenzo C, Habib SL, Jo B, Espinoza SE. Differential effects of metformin on age related comorbidities in older men with type 2 diabetes. J Diabetes Complications 2017;31:679-86. [PMID: 28190681 DOI: 10.1016/j.jdiacomp.2017.01.013] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 13.0] [Reference Citation Analysis]
44 Eldin AB, Elbakry SA, Morad CS, Abd-el-samie AM. The impact of metabolic syndrome on rheumatoid arthritis in a cohort of Egyptian patients. The Egyptian Rheumatologist 2018;40:7-10. [DOI: 10.1016/j.ejr.2017.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Pandey N, Yadav D, Pandey V, Tripathi YB. Anti-inflammatory effect of Pueraria tuberosa extracts through improvement in activity of red blood cell anti-oxidant enzymes. Ayu 2013;34:297-301. [PMID: 24501527 DOI: 10.4103/0974-8520.123131] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
46 Ratajewski M, Walczak-drzewiecka A, Sałkowska A, Dastych J. Upstream Stimulating Factors Regulate the Expression of RORγT in Human Lymphocytes. J I 2012;189:3034-42. [DOI: 10.4049/jimmunol.1200519] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
47 Chimenti MS, Perricone C, Novelli L, Caso F, Costa L, Bogdanos D, Conigliaro P, Triggianese P, Ciccacci C, Borgiani P, Perricone R. Interaction between microbiome and host genetics in psoriatic arthritis. Autoimmunity Reviews 2018;17:276-83. [DOI: 10.1016/j.autrev.2018.01.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
48 Tantayakom P, Koolvisoot A, Arromdee E, Chiowchanwisawakit P, Muangchan C, Katchamart W. Metabolic syndrome is associated with disease activity in patients with rheumatoid arthritis. Joint Bone Spine 2016;83:563-7. [PMID: 27238198 DOI: 10.1016/j.jbspin.2015.10.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
49 Głowińska-Olszewska B, Bossowski A, Dobreńko E, Hryniewicz A, Konstantynowicz J, Milewski R, Łuczyński W, Piotrowska-Jastrzębska J, Kowal-Bielecka O. Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis. Mediators Inflamm 2013;2013:436702. [PMID: 23554546 DOI: 10.1155/2013/436702] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
50 Ramadan G, El-Menshawy O. Protective effects of ginger-turmeric rhizomes mixture on joint inflammation, atherogenesis, kidney dysfunction and other complications in a rat model of human rheumatoid arthritis. Int J Rheum Dis 2013;16:219-29. [PMID: 23773648 DOI: 10.1111/1756-185X.12054] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
51 Kang Y, Park HJ, Kang MI, Lee HS, Lee SW, Lee SK, Park YB. Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 2013;15:R194. [PMID: 24245495 DOI: 10.1186/ar4384] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
52 Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford) 2014;53:2143-54. [PMID: 24907149 DOI: 10.1093/rheumatology/keu224] [Cited by in Crossref: 163] [Cited by in F6Publishing: 137] [Article Influence: 23.3] [Reference Citation Analysis]
53 Gremese E, Tolusso B, Gigante MR, Ferraccioli G. Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). Front Immunol 2014;5:576. [PMID: 25426122 DOI: 10.3389/fimmu.2014.00576] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 9.4] [Reference Citation Analysis]
54 Wilkinson TJ. Oral creatine supplementation: A potential adjunct therapy for rheumatoid arthritis patients. WJR 2014;4:22. [DOI: 10.5499/wjr.v4.i3.22] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
55 Perricone R, Perricone C, Shoenfeld Y. Autoimmunity: when the immune system becomes the self-ish giant. Autoimmun Rev 2011;10:575-6. [PMID: 21621001 DOI: 10.1016/j.autrev.2011.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]